Exploring Squalene and Rhodoxanthin from Hylocereus undatus as a Therapeutic Agent for the Treatment of Human Liver Cancer using Docking Analysis
Chettinad Health City Medical Journal · 2022
DOI: 10.24321/2278.2044.202213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chettinad Health City Medical Journal, 2022. Verfasst von Sivakumari K. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
The dragon fruit H. undatus contains several active phyto-compounds, which act as good antioxidant, anti-inflammatory, and anti-cancer agents. To explore the apoptotic potential of these phyto-compounds, it would be apt to screen the interaction of these compounds with apoptotic proteins via., in silico docking studies.
Method
The current study was planned to evaluate the docking interaction of selected GC-MS spectrum components from H. undatus(squalene and rhodoxanthin) with apoptotic proteins (AIF, Apaf-1, BAK, caspase 8, and RIP) by PatchDock docking algorithm.
Results
The docking interaction showed that rhodoxanthin docks well with apoptotic proteins, and rhodoxanthin is recommended by the Lipinski rule as the best treatment for liver cancer.
Conclusion
The application of rhodoxanthin as a potential and natural therapeutic agent to cure diseases is validated by docking results.
Zitieren
APA
K, S. (2022). Exploring Squalene and Rhodoxanthin from Hylocereus undatus as a Therapeutic Agent for the Treatment of Human Liver Cancer using Docking Analysis. Chettinad Health City Medical Journal. https://doi.org/10.24321/2278.2044.202213
Vancouver
K S. Exploring Squalene and Rhodoxanthin from Hylocereus undatus as a Therapeutic Agent for the Treatment of Human Liver Cancer using Docking Analysis. Chettinad Health City Medical Journal. 2022. doi:10.24321/2278.2044.202213
BibTeX
@article{K2022,
author = {K, Sivakumari},
title = {Exploring Squalene and Rhodoxanthin from Hylocereus undatus as a Therapeutic Agent for the Treatment of Human Liver Cancer using Docking Analysis},
journal = {Chettinad Health City Medical Journal},
year = {2022},
doi = {10.24321/2278.2044.202213}
}
EUVIMED